Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
Aug 1, 2014
Application of Protein Capsular Matrix Vaccine Technology to the Development of a Novel Form of Killed Whole Cell Vaccines
$600,000.00
Apr 1, 2013
Transcutaneous microsphere vaccine technology
$9,000,000.00
Sep 29, 2015
Livestock Vaccine Innovation Fund
$202,725.00
Oct 1, 2018
Influenza vaccines, statins, and laboratory-confirmed influenza outcomes in older adults: can vaccines and statins reduce the burden of influenza?
$90,000,000.00
Aug 4, 2020
Not-for-profit organization or charity
P009527001, P009527002 & P009527003: COVID-19 Vaccine Research and Development
7421492 P009527001 P009527002 P009527003
Equitable access to a vaccine represents one of the greatest hopes to contain and ultimately suppress the pandemic, lessen the burden on developing country health systems, and speed up their economic recovery.
In the implementation of COVID-19 vaccine efforts, CEPI will ensure that awardees addressing sex- and gender-based differences following the WHO’s 2016 Guidance for Managing Ethical Issues in Infectious Disease Outbreaks throughout the research and development process.
$100,000.00
Jul 1, 2016
Public deliberation on vaccine hesitancy
$150,000.00
Apr 1, 2012
Towards a Universal Influenza Virus Vaccine
$105,000.00
Jan 1, 2018
Towards rational design of Salmonella vaccin
$394,826.00
Feb 4, 2015
204891
204891
Facilitate a GMP clinical vaccine manufacture
$1,266,140.00
Dec 1, 2011
The Botswana-Canada AIDS Vaccine Discovery Partnership